Bioxcel Therapeutics deal with Teva includes $57.5M cash
Bioxcel Therapeutics said its deal with Teva includes $57.5 million cash and up to $67.5 million in development milestones.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.